Cargando…
Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases
BACKGROUND: The main challenge in follow-up duration of patients with brain metastases after stereotactic radiotherapy is to distinguish between pseudo-progression and tumor recurrence. The objective of this study is to retrospectively analyze the predictive factors. METHODS: The study included 123...
Autores principales: | Yang, Siran, Ma, Yuchao, Xu, Yingjie, Liu, Qingfeng, Zhang, Ye, Huang, Xiaodong, Chen, Xuesong, Wang, Kai, Zhao, Ruizhi, Xiao, Jianping, Zhang, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930329/ https://www.ncbi.nlm.nih.gov/pubmed/36788610 http://dx.doi.org/10.1186/s13014-023-02214-7 |
Ejemplares similares
-
LOCL-02 DOSIMETRIC AND CLINICAL ANALYSIS OF PSEUDO-PROGRESSION VS. RECURRENCE AFTER HYPER-FRACTIONATED RADIOTHERAPY FOR BRAIN METASTASES BASED ON ENHANCED MAGNETIC RESONANCE IMAGING
por: Yang, Siran, et al.
Publicado: (2022) -
Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
por: Zhao, Ruizhi, et al.
Publicado: (2020) -
The Sequence of Intracranial Radiotherapy and Systemic Treatment With Tyrosine Kinase Inhibitors for Gene-Driven Non-Small Cell Lung Cancer Brain Metastases in the Targeted Treatment Era: A 10-Year Single-Center Experience
por: Yang, Siran, et al.
Publicado: (2021) -
21. A PHASE II TRIAL OF COMPREHENSIVE TREATMENT BASED ON RADIOTHERAPY IN LEPTOMENINGEAL METASTASIS
por: Yang, Siran, et al.
Publicado: (2020) -
Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022)